๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion

โœ Scribed by Watanapa, P; Flaks, B; Oztas, H; Deprez, PH; Calam, J; Williamson, RCN


Book ID
109836845
Publisher
Nature Publishing Group
Year
1993
Tongue
English
Weight
908 KB
Volume
67
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effect of cholecystokinin analogue caeru
โœ Cosimo Sperti; Carmelo Militello; Roubik Behboo; Edwin Khajeturian; Sergio Pedra ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 567 KB

The effects of the cholecystokinin (CCK)-analogue, caerulein, and CCKreceptor antagonist lorglumide (CR-1409) on pancreatic carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) were studied. One hundred thirty rats were divided into the following 10 treatment groups: group 1, DMBA (2-3 mg

Inhibitory effects of a cholecystokinin
โœ Hideki Morimoto; Dr. Yoshinori Nio; Michihiko Tsubono; Chen-Chiu Tseng; Kazuya K ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 676 KB

The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR-1505), on four freshly separated and six xenografted human pancreatic cancers, were investigated. The level of DNA synthesis in only one of five tested pancreatic cancers was enhanced by CCK at concentrations of 0.01-10 nM, w